Skip to content

Effect of Home-Based Transcranial Direct Current Stimulation (tDCS) on Cognitive Function

The Effect of tDCS on Cognitive Function among MCI Patients: a randomized, double blind study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0002721
Enrollment
20
Registered
2018-03-09
Start date
2018-03-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Subjects receive instructional education about tDCS and evaluation before trial. Those who pass the evaluation can receive the tDCS device. Either active or sham tDCS is applied at

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults with the age of 60 or more, but less than 80 (based on resident registration number) 2) Those with subjective memory impairment while maintaining normal general functions and daily life performance 3) Declined cognitive function suggested by Korean Version of the Mini–Mental State Examination for Dementia Screening(MMSE-DS) 4) Seoul-Instrumental Activities of Daily living score 7 or below 5) Korean version of Global Deterioration Scale (GDS) score of 2~3 or Clinical Dementia Rating(CDR) score of 0.5 assessed by the clinician 6) Korean version of Geriatric depression scale(K-GDS) score 8 or below

Exclusion criteria

Exclusion criteria: 1) A person who was diagnosed with the Alzheimer's disease or is currently taking cognitive enhancer such as donepezil, rivastigmine, galantamine, or memantine 2) History of intellectual disability 3) Medical history that can cause cognitive dysfunction 4) A person who is currently diagnosed with alcohol dependence using Diagnostic and Statistical Manual of Mental Disorders 4th edition(DSM-IV) 5) History of seizure 6) A person who suffers from serious dysfunction in cardiovascular, digestive, respiratory, endocrine or central nervous systems 7) A person who received cerebrovascular surgery including brain and carotid artery 8) A person who seems to have a problem with attaching the electrodes due to scalp deformity, inflammatory reaction, or other dermatological reasons 9) A person who is prohibited from applying transcranial direct current stimulation device with other reasons such as a metal plate inserted in cephalic region 10) A person who participated in other clinical trials within 30 days from screening 11) A person who wears glasses, but still are unable to read the ordinary writings because of the visual problem 12) A person who uses the hearing aid, but still has difficulty in understanding the conversation because of the auditory problem 13) Apart from as mentioned above, person with any disqualifying clinical problem determined by the investigator * Patients who take medication for psychiatric treatment or internal disease treatment can be included

Design outcomes

Primary

MeasureTime frame
visual recognition task

Secondary

MeasureTime frame
Letter- Number Sequencing;Spatial Span;Clinical Global Impression;Neuropsychiatric Inventory;The Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery

Countries

Korea, Republic of

Contacts

Public ContactYoonkyung Oh

Yonsei University Health System, Gangnam Severance Hospital

yk9074@yuhs.ac+82-2-2019-5415

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 3, 2026